Yeji
FDA approvalconf 0.97

sunosi — FDA approval

$AXSM · Axsome Therapeutics, Inc. · excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea
Event date
March 20, 2019
2635 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

“Sunosi received U.S. Food and Drug Administration approval on March 20, 2019 to improve wakefulness in adult patients with EDS associated with narcolepsy or OSA”
Source: Press release · 2022-03-28View press release ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

No insider Form 4 activity reported on $AXSM in the 90 days around this event.
← All catalysts for $AXSM